Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy
Date first appeared online 31/12/2004
DOI 10.1056/NEJMoa042274
Authors Bain S.
Journal Name New England Journal of Medicine
Volume 351

Documents